Skip to main content
Skip to main content

Personalized immunotherapy selection for breast cancer

Tech ID:
Principal Investigator:
Professor Qing-Xiang Amy Sang and Professor Jinfeng Zhang
Licensing Manager:
  • Patent Pending

Professors Sang and Zhang  have identified biomarkers that define subgroups of breast cancer and clinically useful classifiers for distinguishing breast cancer subtypes.  The present invention provides methods for selecting a therapy for a patient suffering from breast cancer based on expression levels of biomarkers.  The present invention also provides methods for treating breast cancer.